Blood biomarkers for canine cancer, from human to veterinary oncology - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Veterinary and Comparative Oncology Year : 2022

Blood biomarkers for canine cancer, from human to veterinary oncology


In recent decades, interest in circulating tumour biomarkers is increasing both in human and veterinary oncology. An ideal tumour biomarker would allow early diagnosis of neoplasia, identify it specifically, accurately, establish a prognosis and predict its behaviour, especially regarding different therapeutic solutions. It would also allow to monitor its evolution over time and all this in a non-invasive and inexpensive way. Actually, no biomarkers meeting all of these criteria have been identified in veterinary medicine, particularly due to a lack of specificity of the main protein tumour biomarkers studied to date. However, great hope is currently placed in biomarkers grouped under the name of liquid biopsy, which could prove to be effective tools for common clinical use in the near future. This review gives an update on blood cancer biomarkers studied in dogs, such as ions, proteins, nucleic acids and also circulating cells, of which some might become more prominent in the coming years to help improve the management of animal care.
Fichier principal
Vignette du fichier
2022_Colombe_Vet_Comp_Oncol.pdf (1.35 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY - Attribution

Dates and versions

hal-04011686 , version 1 (02-03-2023)





Philippe Colombe, Jérémy Béguin, Ghita Benchekroun, Delphine Le Roux. Blood biomarkers for canine cancer, from human to veterinary oncology. Veterinary and Comparative Oncology, 2022, 20 (4), pp.767-777. ⟨10.1111/vco.12848⟩. ⟨hal-04011686⟩
6 View
2 Download



Gmail Facebook Twitter LinkedIn More